It’s pretty clear who the targets are by looking at the FDA actions and no shelf registration from the SEC. The last 10q laid out the issues being investigated, deny this fact all you want.
The “ short BLA” then immediately selling the majority of shares by Nader, SK and others, smacks of inside trading and fraud.
News 
Market Data 
Discover 
